FDA grants approval for Obalon 3-Balloon System to help achieve weight loss

NewsGuard 100/100 Score

The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.

The Obalon Balloon System is non-surgical treatment that consists of 3 lightweight balloons, placed gradually over 6 months. The balloons occupy space in your stomach so that you feel full and less hungry, making weight loss easier. This 6-month treatment should be accompanied by a professionally-supervised diet and exercise program.

Adam Smith, D.O., FACOS and Richard Novack, M.D., FACS at Ultimate Bariatrics are one of the first practices in Texas offering the Obalon 3-Balloon System. Consultations are done in both Irving and Fort Worth offices but procedures will be done in the Irving/Dallas office initially. In his ongoing quest to stand up for the rights of the obese population, Dr. Smith served as a spokesperson by the Obesity Action Coalition as a part of the Voice My C.H.O.I.C.E. campaign, he served as the President of the American College of Osteopathic Surgeons in 2013, and is a member of many professional medical societies.​

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study offers insight into state Medicaid coverage for anti-obesity drugs